NEOsphere Biotechnologies GmbH
PrivateLast Round
Series A
Jul 25, 2022
Total Funding Raised
$6.13M
Company Overview
NEOsphere Biotechnologies GmbH operates in Healthcare & Life Sciences and is based in Planegg. Its latest recorded funding round was a Series A round in July 2022.
NEOsphere Biotechnologies GmbH is a biotechnology company that provides high-throughput proteomics services to support targeted protein degradation drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NEOsphere Biotechnologies GmbH Comparables
Compare NEOsphere Biotechnologies GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Proxygen | 78% | |
| Ubiquigent Limited | 74% | |
| Bruker | 72% |
For institutional investors. Book with your work email.
NEOsphere Biotechnologies GmbH Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
NEOsphere Biotechnologies GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ventura BioMed Investors | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 20, 2025
Grew 30% QoQ, from 10 to 13 employees.
- Nov 28, 2024
Grew 30% QoQ, from 10 to 13 employees.
For institutional investors. Book with your work email.
NEOsphere Biotechnologies GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NEOsphere Biotechnologies GmbH's valuation, stock price, and market status.
Is NEOsphere Biotechnologies GmbH a public or private company?
NEOsphere Biotechnologies GmbH is a private company.
What is the current stock price of NEOsphere Biotechnologies GmbH?
NEOsphere Biotechnologies GmbH is a private company, so its shares have no public market price. Caplight tracks NEOsphere Biotechnologies GmbH's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NEOsphere Biotechnologies GmbH worth (valuation)?
Valuation information for NEOsphere Biotechnologies GmbH is not publicly available.
Can I buy NEOsphere Biotechnologies GmbH stock?
NEOsphere Biotechnologies GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NEOsphere Biotechnologies GmbH's last funding round?
NEOsphere Biotechnologies GmbH's most recent funding round was Series A on July 25, 2022.
Who are the main investors in NEOsphere Biotechnologies GmbH?
Key investors in NEOsphere Biotechnologies GmbH include Ventura BioMed Investors.
Will NEOsphere Biotechnologies GmbH IPO soon?
No public IPO plans have been announced for NEOsphere Biotechnologies GmbH.
How can I track NEOsphere Biotechnologies GmbH secondary market activity?
Caplight tracks bids, offers, and trades in NEOsphere Biotechnologies GmbH's shares on secondary markets.